UNSPSC 51282406: Fuzlocillin

This classification denotes a penicillin antibiotic with the molecular formula C25H26N6O8S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier J6UQP7JHOT, chemically known as (2s,5r,6r)-6-((2r)-2-(3-((e)-furfurylideneamino)-2-oxo-1-imidazolidinecarboxamido)-2-(p-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid but generally known as fuzlocillin, which bears US NIH Compound Identifier 9571079.

UNSPSC 51282406 Fuzlocillin is a Commodity code that does not map to actual recent state and local procurement activity. The code's nominal scope — fuzlocillin, a pharmaceutical active ingredient — bears no relation to the opportunities tagged under it in recent postings. Seminole County, Florida solicited naloxone and drug deactivation systems; the City of Tampa solicited medical and first aid supplies for fire rescue; the Texas Health and Human Services Commission issued a Request for Information on direct-to-manufacturer prescription programs; and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) solicited generic multi-source pharmaceuticals and over-the-counter products. None of these procurements involve fuzlocillin. The code shows a tagging or classification error rather than active buying demand.

The recent opportunities themselves span naloxone (a life-saving opioid antagonist), medical consumables and emergency response supplies, pharmacy benefit management infrastructure, and broad generic pharmaceutical distribution. Issuing bodies include a county health department, a municipal fire department, a state health agency, and a multi-state cooperative purchasing coalition serving state and local facilities across multiple states including Minnesota and Oregon. Geographic activity appears in Florida, Texas, and the multi-state MMCAP network. The mismatch between the fuzlocillin code name and the actual content of tagged opportunities suggests that state and local procurement offices are either miscoding pharmaceutical solicitations or that the code itself is misaligned with current market activity. Pursuit under this code warrants confirmation that your target customer is actually buying fuzlocillin, not relying on a misapplied classification.